Sentiment-Signal
15,6
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
13.8
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
Unternehmen & Branche
| Name | CERUS CORP |
|---|---|
| Ticker | CERS |
| CIK | 0001020214 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | 157085101 |
|---|---|
| ISIN | US1570851014 |
| Typ | Common Stock |
| Marktkapitalisierung | 393,0 Mio. USD |
| Beta | 1,63 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 233,798,000 | -15,627,000 | -0.08 | 221,859,000 | 64,224,000 |
| 2025-09-30 | 10-Q | -19,000 | 0.00 | 215,185,000 | 61,463,000 | |
| 2025-06-30 | 10-Q | -5,707,000 | -0.03 | 213,071,000 | 55,428,000 | |
| 2025-03-31 | 10-Q | -7,717,000 | -0.04 | 206,776,000 | 55,492,000 | |
| 2024-12-31 | 10-K | 201,321,000 | -20,918,000 | -0.11 | 200,917,000 | 56,145,000 |
| 2024-09-30 | 10-Q | -2,934,000 | -0.02 | 189,539,000 | 53,489,000 | |
| 2024-06-30 | 10-Q | -5,775,000 | -0.03 | 185,496,000 | 49,509,000 | |
| 2024-03-31 | 10-Q | -9,688,000 | -0.05 | 189,136,000 | 49,370,000 | |
| 2023-12-31 | 10-K | 186,797,000 | -37,489,000 | -0.21 | 197,748,000 | 52,650,000 |
| 2023-09-30 | 10-Q | -7,267,000 | -0.04 | 205,844,000 | 48,168,000 | |
| 2023-06-30 | 10-Q | -13,275,000 | -0.07 | 198,860,000 | 50,816,000 | |
| 2023-03-31 | 10-Q | -15,619,000 | -0.09 | 209,336,000 | 58,632,000 | |
| 2022-12-31 | 10-K | 188,315,000 | -42,779,000 | -0.24 | 218,092,000 | 67,610,000 |
| 2022-09-30 | 10-Q | -8,482,000 | -0.05 | 215,403,000 | 73,120,000 | |
| 2022-06-30 | 10-Q | -8,389,000 | -0.05 | 216,456,000 | 75,769,000 | |
| 2022-03-31 | 10-Q | -12,284,000 | -0.07 | 221,906,000 | 79,413,000 | |
| 2021-12-31 | 10-K | 159,518,000 | -54,374,000 | -0.32 | 237,499,000 | 84,619,000 |
| 2021-09-30 | 10-Q | -12,437,000 | -0.07 | 218,946,000 | 80,075,000 | |
| 2021-06-30 | 10-Q | -15,361,000 | 223,223,000 | 84,237,000 | ||
| 2021-03-31 | 10-Q | -17,457,000 | 220,582,000 | 92,635,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 21,918,903 | 0 | 21,918,903 | 45,152,941 | Neu | +100,0% | |
| ARK Investment Management LLC | 18,200,204 | 0 | 18,200,204 | 37,492,420 | Neu | +100,0% | |
| VANGUARD GROUP INC | 11,163,121 | 0 | 11,163,121 | 22,996,030 | Neu | +100,0% | |
| BAKER BROS. ADVISORS LP | 10,008,345 | 0 | 10,008,345 | 20,617,191 | Neu | +100,0% | |
| WASATCH ADVISORS LP | 5,462,616 | 0 | 5,462,616 | 11,252,989 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 4,489,737 | 0 | 4,489,737 | 9,250,981 | Neu | +100,0% | |
| Soleus Capital Management, L.P. | 4,000,000 | 0 | 4,000,000 | 8,240,000 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 3,873,371 | 0 | 3,873,371 | 7,979,145 | Neu | +100,0% | |
| STATE STREET CORP | 3,844,947 | 0 | 3,844,947 | 7,920,591 | Neu | +100,0% | |
| IEQ CAPITAL, LLC | 2,423,741 | 0 | 2,423,741 | 4,992,906 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 2,407,776 | 0 | 2,407,776 | 4,960,018 | Neu | +100,0% | |
| AQR CAPITAL MANAGEMENT LLC | 2,003,198 | 0 | 2,003,198 | 4,126,588 | Neu | +100,0% | |
| MORGAN STANLEY | 1,940,157 | 0 | 1,940,157 | 3,996,723 | Neu | +100,0% | |
| TWO SIGMA INVESTMENTS, LP | 1,857,110 | 0 | 1,857,110 | 3,825,647 | Neu | +100,0% | |
| Assenagon Asset Management S.A. | 1,676,279 | 0 | 1,676,279 | 3,453,135 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,666,928 | 0 | 1,666,928 | 3,433,872 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 1,446,971 | 0 | 1,446,971 | 2,980,760 | Neu | +100,0% | |
| VOYA INVESTMENT MANAGEMENT LLC | 1,194,535 | 0 | 1,194,535 | 2,460,742 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 1,179,020 | 0 | 1,179,020 | 2,428,780 | Neu | +100,0% | |
| UBS Group AG | 1,142,502 | 0 | 1,142,502 | 2,353,554 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 1,050,820 | 0 | 1,050,820 | 2,164,689 | Neu | +100,0% | |
| FMR LLC | 1,033,272 | 0 | 1,033,272 | 2,128,540 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 967,694 | 0 | 967,694 | 1,993,450 | Neu | +100,0% | |
| BARCLAYS PLC | 890,741 | 0 | 890,741 | 1,834,926 | Neu | +100,0% | |
| PRIMECAP MANAGEMENT CO/CA/ | 794,500 | 0 | 794,500 | 1,636,670 | Neu | +100,0% | |
| Connor, Clark & Lunn Investment Management Ltd. | 653,190 | 0 | 653,190 | 1,345,571 | Neu | +100,0% | |
| GLOBEFLEX CAPITAL L P | 522,099 | 0 | 522,099 | 1,075,524 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 498,000 | 0 | 498,000 | 1,025,880 | Neu | +100,0% | |
| Topline Capital Management, LLC | 410,963 | 0 | 410,963 | 846,584 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 379,507 | 0 | 379,507 | 781,784 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 347,000 | 0 | 347,000 | 714,820 | Neu | +100,0% | |
| STIFEL FINANCIAL CORP | 324,173 | 0 | 324,173 | 667,799 | Neu | +100,0% | |
| Invesco Ltd. | 309,168 | 0 | 309,168 | 636,886 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 282,970 | 0 | 282,970 | 582,919 | Neu | +100,0% | |
| LAZARD ASSET MANAGEMENT LLC | 273,551 | 0 | 273,551 | 563,515 | Neu | +100,0% | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 255,961 | 0 | 255,961 | 527,280 | Neu | +100,0% | |
| RAYMOND JAMES FINANCIAL INC | 255,545 | 0 | 255,545 | 526,423 | Neu | +100,0% | |
| XTX Topco Ltd | 253,246 | 0 | 253,246 | 521,687 | Neu | +100,0% | |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 365,987 | 0 | 365,987 | 512,382 | Neu | +100,0% | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 235,000 | 0 | 235,000 | 484,100 | Neu | +100,0% | |
| RHUMBLINE ADVISERS | 229,387 | 0 | 229,387 | 472,528 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 228,463 | 0 | 228,463 | 470,634 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 220,129 | 0 | 220,129 | 453,466 | Neu | +100,0% | |
| HSBC HOLDINGS PLC | 203,922 | 0 | 203,922 | 421,099 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 168,253 | 0 | 168,253 | 346,601 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 149,427 | 0 | 149,427 | 307,820 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 147,757 | 0 | 147,757 | 304,379 | Neu | +100,0% | |
| Engineers Gate Manager LP | 142,958 | 0 | 142,958 | 294,493 | Neu | +100,0% | |
| Focus Partners Wealth | 120,726 | 0 | 120,726 | 248,696 | Neu | +100,0% | |
| Squarepoint Ops LLC | 101,983 | 0 | 101,983 | 210,085 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-12 | Greenman William Mariner | Director, Officer, President and CEO | Open Market Sale | -447,757 | 1.66 | -742,022.90 | -485,0% | |
| 2026-03-12 | Jayaraman Vivek K | Officer, Chief Operating Officer | Open Market Sale | -165,200 | 1.66 | -273,769.44 | -178,9% | |
| 2026-03-12 | Green Kevin Dennis | Officer, Chief Financial Officer | Open Market Sale | -127,544 | 1.66 | -211,365.92 | -138,2% | |
| 2026-03-12 | Benjamin Richard J | Officer, Chief Medical Officer | Open Market Sale | -101,740 | 1.66 | -168,603.53 | -110,2% | |
| 2026-03-09 | Benjamin Richard J | Officer, Chief Medical Officer | Open Market Sale | -40,426 | 1.88 | -76,029.18 | -49,7% | |
| 2026-03-09 | Benjamin Richard J | Officer, Chief Medical Officer | Open Market Sale | -40,426 | 1.88 | -76,029.18 | -49,7% | |
| 2026-03-06 | Jensen Chrystal | Officer, Chief Legal Officer | Open Market Sale | -30,845 | 2.01 | -61,859.65 | -40,4% | |
| 2026-03-06 | Green Kevin Dennis | Officer, Chief Financial Officer | Open Market Sale | -27,796 | 2.01 | -55,744.88 | -36,4% | |
| 2026-03-06 | Jayaraman Vivek K | Officer, Chief Operating Officer | Open Market Sale | -34,094 | 2.01 | -68,375.52 | -44,7% | |
| 2026-03-06 | Greenman William Mariner | Director, Officer, President and CEO | Open Market Sale | -78,187 | 2.01 | -156,804.03 | -102,5% | |
| 2026-03-06 | Benjamin Richard J | Officer, Chief Medical Officer | Open Market Sale | -24,235 | 2.01 | -48,603.29 | -31,8% | |
| 2026-03-06 | Benjamin Richard J | Officer, Chief Medical Officer | Open Market Sale | -24,235 | 2.01 | -48,603.29 | -31,8% | |
| 2026-03-05 | Benjamin Richard J | Officer, Chief Medical Officer | Open Market Sale | -61,233 | 2.06 | -126,299.19 | -82,6% | |
| 2026-03-05 | Benjamin Richard J | Officer, Chief Medical Officer | Open Market Sale | -61,233 | 2.06 | -126,305.31 | -82,6% | |
| 2026-03-05 | Green Kevin Dennis | Officer, Chief Financial Officer | Open Market Sale | -55,225 | 2.06 | -113,901.56 | -74,5% | |
| 2025-11-24 | Jensen Chrystal | Officer, Chief Legal Officer | Open Market Sale | -55,000 | 1.70 | -93,500.00 | -61,1% |
Fail-to-Deliver (6 Monate)
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-03-20 | 5.000 | 1,76 | 8.800 |
| 2026-03-03 | 21.851 | 2,53 | 55.283 |
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| BlackRock, Inc. | 21,918,903 | 45,152,941 | 18.99 |
| ARK Investment Management LLC | 18,200,204 | 37,492,420 | 15.77 |
| VANGUARD GROUP INC | 11,163,121 | 22,996,030 | 9.67 |
| BAKER BROS. ADVISORS LP | 10,008,345 | 20,617,191 | 8.67 |
| WASATCH ADVISORS LP | 5,462,616 | 11,252,989 | 4.73 |
| GEODE CAPITAL MANAGEMENT, LLC | 4,489,737 | 9,250,981 | 3.89 |
| Soleus Capital Management, L.P. | 4,000,000 | 8,240,000 | 3.47 |
| D. E. Shaw & Co., Inc. | 3,873,371 | 7,979,145 | 3.36 |
| STATE STREET CORP | 3,844,947 | 7,920,591 | 3.33 |
| IEQ CAPITAL, LLC | 2,423,741 | 4,992,906 | 2.10 |
| GOLDMAN SACHS GROUP INC | 2,407,776 | 4,960,018 | 2.09 |
| AQR CAPITAL MANAGEMENT LLC | 2,003,198 | 4,126,588 | 1.74 |
| MORGAN STANLEY | 1,940,157 | 3,996,723 | 1.68 |
| TWO SIGMA INVESTMENTS, LP | 1,857,110 | 3,825,647 | 1.61 |
| Assenagon Asset Management S.A. | 1,676,279 | 3,453,135 | 1.45 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,666,928 | 3,433,872 | 1.44 |
| NORTHERN TRUST CORP | 1,446,971 | 2,980,760 | 1.25 |
| VOYA INVESTMENT MANAGEMENT LLC | 1,194,535 | 2,460,742 | 1.03 |
| BANK OF AMERICA CORP /DE/ | 1,179,020 | 2,428,780 | 1.02 |
| UBS Group AG | 1,142,502 | 2,353,554 | 0.99 |